EGFR amplification is typical of highly aggressive primary GBM; about 50% of these tumours present a truncated and constitutively active form of EGFR (EGFRvIII), lacking part of the extracellular domain as a result of exons 2–7 deletion [37]. The gene discussed is EGFR; the disease is glioblastoma.